Literature DB >> 16307758

Channel opening motion of alpha7 nicotinic acetylcholine receptor as suggested by normal mode analysis.

Xiaolin Cheng1, Benzhuo Lu, Barry Grant, Richard J Law, J Andrew McCammon.   

Abstract

The gating motion of the human nicotinic acetylcholine receptor (nAChR) alpha7 was investigated with normal mode analysis (NMA) of two homology models. The first model, referred to as model I, was built from both the Lymnaea stagnalis acetylcholine binding protein (AChBP) and the transmembrane (TM) domain of the Torpedo marmorata nAChR. The second model, referred to as model C, was based solely on the recent electron microscopy structure of the T. marmorata nAChR. Despite structural differences, both models exhibit nearly identical patterns of flexibility and correlated motions. In addition, both models show a similar global twisting motion that may represent channel gating. The similar results obtained for the two models indicate that NMA is most sensitive to the contact topology of the structure rather than its finer detail. The major difference between the low-frequency motions sampled for the two models is that a symmetrical pore-breathing motion, favoring channel opening, is present as the second most dominant motion in model I, whilst largely absent from model C. The absence of this mode in model C can be attributed to its less symmetrical architecture. Finally, as a further goal of the present study, an approximate open channel model, consistent with many experimental findings, has been produced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307758     DOI: 10.1016/j.jmb.2005.10.039

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  62 in total

1.  Tightening of the ATP-binding sites induces the opening of P2X receptor channels.

Authors:  Ruotian Jiang; Antoine Taly; Damien Lemoine; Adeline Martz; Olivier Cunrath; Thomas Grutter
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

2.  Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.

Authors:  Toby Collins; Neil S Millar
Journal:  Mol Pharmacol       Date:  2010-05-12       Impact factor: 4.436

Review 3.  Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening.

Authors:  Elaine A Gay; Jerrel L Yakel
Journal:  J Physiol       Date:  2007-09-06       Impact factor: 5.182

4.  Normal-mode analysis of the glycine alpha1 receptor by three separate methods.

Authors:  Edward J Bertaccini; James R Trudell; Erik Lindahl
Journal:  J Chem Inf Model       Date:  2007-06-30       Impact factor: 4.956

Review 5.  Opened by a twist: a gating mechanism for the nicotinic acetylcholine receptor.

Authors:  Antoine Taly
Journal:  Eur Biophys J       Date:  2007-07-04       Impact factor: 1.733

6.  Inhibition mechanism of the acetylcholine receptor by alpha-neurotoxins as revealed by normal-mode dynamics.

Authors:  Abraham O Samson; Michael Levitt
Journal:  Biochemistry       Date:  2008-03-08       Impact factor: 3.162

7.  End-point targeted molecular dynamics: large-scale conformational changes in potassium channels.

Authors:  R J Mashl; E Jakobsson
Journal:  Biophys J       Date:  2008-02-29       Impact factor: 4.033

8.  Ensemble refinement of protein crystal structures: validation and application.

Authors:  Elena J Levin; Dmitry A Kondrashov; Gary E Wesenberg; George N Phillips
Journal:  Structure       Date:  2007-09       Impact factor: 5.006

Review 9.  A gating mechanism of pentameric ligand-gated ion channels.

Authors:  Nicolas Calimet; Manuel Simoes; Jean-Pierre Changeux; Martin Karplus; Antoine Taly; Marco Cecchini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors.

Authors:  Antoine Taly; Pierre-Jean Corringer; Thomas Grutter; Lia Prado de Carvalho; Martin Karplus; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.